COVID-19 frequently causes elevated liver enzymes, with abnormal results reported in roughly 14 to 53 percent of patients depending on the study and the specific enzyme measured.1Springer Link (Digestive Diseases and Sciences). Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard In most cases, the elevations are mild and resolve on their own. But the relationship between the virus and the liver turns out to be more layered than a single mechanism would suggest, and in a minority of patients the damage can be severe or long-lasting.
How Common Are Liver Enzyme Elevations in COVID Patients?
Among hospitalized COVID patients, the numbers are striking. A large retrospective study of over 1,800 patients in a major U.S. hospital network found that about two-thirds had abnormal AST at the time of admission, and roughly 40 percent had abnormal ALT. By the time enzymes peaked during hospitalization, those numbers climbed further: over 80 percent for AST and about 60 percent for ALT.2PubMed Central. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network Bilirubin elevations, which reflect a somewhat different aspect of liver function, were less common but still present in roughly 10 to 35 percent of patients across multiple studies.1Springer Link (Digestive Diseases and Sciences). Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard
Not every study reported the same rates. A Chinese retrospective cohort found lower percentages at admission — around 13 percent for ALT and about 9 percent for AST — though these still rose substantially during hospitalization.3PubMed Central. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study The variation likely reflects differences in disease severity across study populations: sicker patients with more inflammation tend to show higher rates. But the overall takeaway is consistent. Abnormal liver tests are one of the more common laboratory findings in COVID, even in patients who have no known liver disease going in.
What Pattern Do the Enzyme Elevations Follow?
When clinicians see abnormal liver enzymes, the pattern matters. A “hepatocyte” pattern means the enzymes that leak from damaged liver cells (AST and ALT) are the most elevated. A “cholestatic” pattern means the enzymes associated with bile flow problems (alkaline phosphatase and GGT) dominate. COVID produces both, plus a large number of mixed presentations. One study analyzing the breakdown found that about 21 percent of patients had a hepatocyte pattern, about 29 percent had a cholestatic pattern, and roughly 43 percent had a mixed pattern.4Journal of Hepatology. COVID-19: Abnormal liver function tests
The dominance of mixed-pattern elevations is a clue that multiple injury mechanisms are at work simultaneously. If the virus were simply killing liver cells, you’d expect a pure hepatocyte pattern. If it were purely blocking bile ducts, you’d see cholestatic numbers. The fact that most patients show a blend suggests the liver is being hit from several directions at once.
Why Does COVID Affect the Liver?
Researchers have identified several pathways by which the virus damages the liver, and they often operate in parallel.
The Virus Itself
SARS-CoV-2 can enter liver cells and bile duct cells through surface receptors, including the well-known ACE2 receptor.5PubMed Central. Hepatic complications of COVID-19 and its treatment Additional receptors on liver cells, including Toll-like receptors and others involved in innate immune sensing, provide further entry points.6PubMed Central. Mechanisms of severe acute respiratory syndrome coronavirus-2 induced liver damage and alteration of some liver biomarkers: A review Once inside, the virus can replicate and cause the cell to die, releasing enzymes into the bloodstream. That said, autopsy studies have generally not found abundant viral particles actively infecting hepatic cells, suggesting that direct viral attack explains only part of the picture.7PubMed Central. Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens
The Inflammatory Response
The body’s immune reaction to the virus may do more harm to the liver than the virus itself. In severe COVID, the immune system can produce a flood of inflammatory signaling molecules. This “cytokine storm” is now considered the leading hypothesis for COVID-related liver injury.8PubMed. Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots Patients with elevated AST showed significantly higher levels of IL-6, ferritin, LDH, and CRP — all markers of systemic inflammation — compared to patients with normal liver enzymes. In ICU patients, the link between inflammation and liver injury was even stronger.9PubMed Central. Systemic inflammation as fuel for acute liver injury in COVID-19
Oxygen Deprivation
Severe COVID damages the lungs, and when the lungs can’t oxygenate blood properly, the liver suffers. The combination of low oxygen and reduced blood flow — from shock, mechanical ventilation, or both — creates what’s called ischemic or hypoxic liver injury. This type of damage tends to produce very high aminotransferase levels in the bloodstream, sometimes strikingly elevated.10PubMed Central. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease Along with cytokine storm, ischemia and hypoxia are considered the three major drivers of COVID-related liver damage.11PubMed Central. Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19
Blood Clots in the Liver
COVID promotes clotting throughout the body, and the liver’s tiny blood vessels are not spared. An autopsy study of 43 patients found that over half had small blood clots (microthrombi) within the liver’s sinusoids — the narrow channels where blood flows through the organ. Patients with these clots had ALT levels roughly ten times higher than those without them.12PubMed Central. Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients: A series of 43 cases Another autopsy series found platelet-fibrin microthrombi in the liver sinusoids of most patients examined, sometimes accompanied by areas of tissue death.13EClinicalMedicine. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series These microthrombi can also form in the lungs, kidneys, heart, and brain.14PubMed Central. Pulmonary and Systemic Pathology in COVID-19—Holistic Pathological Analyses
What the Liver Actually Looks Like Under the Microscope
Autopsy studies paint a more nuanced picture than blood tests alone. The most frequent microscopic findings in the livers of people who died of COVID were congestion (present in about 43 percent of cases) and fatty changes, or steatosis (about 42 percent). Inflammation and tissue death were less common, each found in roughly one in five cases. And despite the blood-clotting story described above, full-blown microthrombi in the liver’s vascular tree were found in only about 12 percent of autopsy cases — far less often than in the lungs.15PubMed Central. Liver pathology in COVID-19 related death and leading role of autopsy in the pandemic
One biopsy-and-autopsy series found mild or absent inflammatory hepatitis in most specimens, with the main changes being activation of immune cells within the liver and signs of liver cell regeneration. No active viral particles were found infecting the liver or its blood vessel lining. The researchers concluded that the damage appeared to be an indirect consequence of the infection or the treatments used, rather than direct viral destruction of liver tissue.7PubMed Central. Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens This is worth underscoring: the liver enzyme elevations most people experience during COVID are typically not accompanied by dramatic tissue destruction. They reflect stress and inflammation more than outright organ failure.
Do Elevated Liver Enzymes Predict Worse Outcomes?
Yes, and fairly consistently. Across multiple studies, patients whose liver enzymes went up had higher rates of ICU admission, intubation, and death compared to COVID patients with normal liver tests.16PubMed Central. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2 One Greek study found that patients with abnormal AST at admission had significantly worse survival.17PubMed Central. Prevalence of abnormal liver biochemistry and its impact on COVID-19 patients’ outcomes: a single-center Greek study
The type of enzyme elevation matters, though. A Saudi Arabian study using multivariate analysis found that elevated hepatocyte-type enzymes (AST, ALT) were significantly associated with mortality, while cholestatic enzyme elevations (alkaline phosphatase) were not.18PubMed Central. Impact of Elevated Liver Enzymes on the Severity of Clinical Course of COVID-19: A Retrospective Study From Saudi Arabia A fibrosis scoring tool called FIB-4, which uses standard liver tests along with age and platelet count, also showed strong associations with mortality in COVID patients, even after adjusting for other risk factors.19PubMed Central. Liver Function Tests and FIB-4 Score as Predictors of Severity in COVID-19 Patients from the South-West of Romania
That said, elevated liver enzymes here are probably a marker of overall disease severity rather than a cause of death in themselves. Sicker patients have more inflammation, more organ stress, and more medication exposure — all of which drive enzymes up. Liver enzyme monitoring during hospitalization nonetheless gives clinicians useful information about how the disease is progressing.
Can COVID Treatments Themselves Raise Liver Enzymes?
This is one of the trickier aspects of interpreting liver tests during COVID. Several of the medications used to treat the disease are known to stress the liver. Remdesivir, one of the earliest antivirals authorized for COVID treatment, has been associated with transaminase elevations in data from randomized controlled trials, and clinicians have been cautioned to monitor liver function closely when using it.20PubMed Central. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness Tocilizumab, an anti-inflammatory drug used in severe COVID, has also been linked to liver injury in pharmacovigilance analyses.21PubMed Central. Drug-induced liver injury and COVID-19: A review for clinical practice
During the pandemic’s early phases, many drugs were used off-label at a large scale, and distinguishing drug-induced liver injury from infection-related liver injury in a critically ill patient is genuinely difficult. Both can present with the same enzyme pattern. Baseline liver testing before starting treatment, avoiding stacking multiple liver-toxic drugs simultaneously, and regular monitoring during therapy remain the practical approach.
What If You Already Have Liver Disease?
People with pre-existing liver conditions face a compounding situation. Existing fatty liver disease, for example, can worsen the course of COVID, and COVID’s inflammatory effects can accelerate damage in a liver that was already stressed.22PubMed Central. Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? This is a two-way street: the metabolic inflammation that accompanies fatty liver may amplify the immune overreaction to the virus, while the virus-induced inflammation may push a borderline liver into more overt dysfunction.
The gut may play a role in this interplay as well. SARS-CoV-2 infects cells lining the intestines, and the resulting intestinal damage, combined with the widespread vascular inflammation the virus causes, can increase the permeability of the gut wall. When the gut barrier becomes leaky, bacteria and their toxic products can spill into the portal circulation and reach the liver directly, adding another source of injury.23PubMed Central. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis For someone whose liver is already dealing with chronic inflammation from fatty liver or another condition, this extra insult can push things further.
Can Liver Problems Persist After COVID Resolves?
For most people, liver enzyme elevations are temporary and return to normal as the infection clears. But a growing body of research shows that some patients experience liver-related effects that linger well beyond the acute illness. A cross-sectional study of long-COVID patients found that markers of liver injury, including ALT, AST, LDH, GGT, and ferritin, remained abnormal and could persist for more than a year and a half after recovery from the initial infection.24PubMed Central. Liver Function in Patients with Long-Term Coronavirus Disease 2019 of up to 20 Months: A Cross-Sectional Study A narrative review noted that liver manifestations of long COVID can range from persistent, asymptomatic enzyme elevations all the way to cholangiopathy and even fibrosis, particularly in patients who also have metabolic disorders or obesity.25PubMed Central. Multiorgan Involvement and Particularly Liver Injury in Long COVID: A Narrative Review
One of the more serious long-term complications is a condition called secondary sclerosing cholangitis, where the bile ducts become scarred and narrowed. This has been described primarily in patients who had critical COVID requiring ICU care, mechanical ventilation, and vasopressor support.26PubMed Central. Secondary sclerosing cholangitis after critical COVID-19: Three case reports The damage appears to be ischemic in nature — reduced blood flow to the bile ducts during the critical illness injures the duct lining, leading to scarring and persistent cholestasis. One study found that this complication occurred in COVID patients but not in a comparison group of patients hospitalized for severe influenza A, suggesting something specific about severe COVID’s vascular effects.27PubMed Central. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19 This is rare, but for patients who develop it, the consequence is chronic liver disease.
Can COVID Trigger Autoimmune Hepatitis?
Case reports have described the onset of autoimmune hepatitis following SARS-CoV-2 infection. In one documented case, a patient developed severely elevated liver enzymes — ALT over 600 U/L, AST over 2,300 U/L — along with autoimmune antibodies, following a COVID infection.28PubMed Central. Onset of acute severe autoimmune hepatitis after severe acute respiratory syndrome coronavirus 2 infection: a case report The idea is that the intense immune activation triggered by the virus can break the body’s tolerance to its own liver tissue, essentially tripping the immune system into attacking the liver.
This is not unique to COVID — other viral infections have long been known to trigger autoimmune hepatitis in genetically susceptible individuals. But given the sheer number of people who have been infected with SARS-CoV-2, even a low probability event translates into a meaningful number of cases. Clinicians are now advised to consider autoimmune hepatitis in the workup for any patient with persistently or severely elevated liver enzymes after COVID, particularly if the pattern doesn’t fit the usual mild, self-resolving picture.
What About Children?
Children generally have milder COVID than adults, but liver enzyme elevations can occur in pediatric cases, especially in the context of multisystem inflammatory syndrome in children (MIS-C). In one observational study, about half of children in the MIS-C group had elevated transaminases.29PubMed Central. Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study MIS-C is a delayed inflammatory response that typically occurs weeks after the initial infection, and liver involvement appears to be one of its more common features. As with adults, the enzyme elevations in children tend to reflect the overall level of systemic inflammation rather than isolated liver disease.
Do COVID Vaccines Cause Liver Enzyme Elevations?
This question came up frequently during vaccine rollout, so it’s worth addressing directly. A large comparative study found that unexplained liver test abnormalities occurred in about 0.038 percent of individuals following SARS-CoV-2 vaccination, which was actually lower than the rate seen after influenza vaccination (0.069 percent).30PubMed Central. Unexplained liver test elevations after SARS-CoV-2 vaccination A separate study examining both the Pfizer mRNA vaccine and the CoronaVac inactivated vaccine found no increased risk of acute liver injury in the 56 days following either the first or second dose. By contrast, patients who actually had SARS-CoV-2 infection showed a dramatically higher rate of acute liver injury.31PubMed Central. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines No severe or fatal cases of liver injury were observed after vaccination in that study. The evidence is clear that the vaccines carry far less liver risk than the infection itself.
When Elevated Enzymes Are Found Incidentally
Many people discover they had liver enzyme elevations only because blood work was drawn for another reason during or after a COVID infection. If you’re looking at a lab result showing mildly elevated ALT or AST after a bout of COVID, here is some practical context. Mild elevations (less than two or three times the upper limit of normal) during or shortly after COVID are common and typically resolve within weeks. They usually don’t require any specific treatment or urgent follow-up beyond a repeat check after the infection clears.
More concerning situations include enzymes that are severely elevated (five times the upper limit or more), enzymes that keep rising rather than trending downward, new jaundice (yellowing of the skin or eyes), or elevations that persist for months after recovery. Any of these warrants further investigation, which might include imaging, additional blood tests to rule out autoimmune conditions or viral hepatitis, and potentially a referral to a liver specialist. People who were critically ill with COVID, particularly those who required ICU-level care, should have their liver function followed more closely after discharge, given the risk of delayed complications like sclerosing cholangitis.
It’s also worth noting that many commonly used over-the-counter medications — acetaminophen (Tylenol) chief among them — can stress the liver on their own. If you were taking fever-reducing medications regularly during a COVID infection, part of a mild enzyme bump could reflect that overlap rather than the virus alone. This is another reason why the trend over time matters more than any single lab value.